Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

In low- and middle-income countries (LMICs), the clinical management and surveillance of central nervous system (CNS) and bloodstream infections are hindered by the lack of access to timely and accurate diagnostics suitable for resource-limited settings. Bottlenecks in laboratory confirmation, from specimen collection to processing, further exacerbate these challenges. While many of these challenges appear basic, innovative solutions are required to overcome them. Dr. Kwambana-Adams’ lecture will cover practical solutions that her group and others are developing to enhance the laboratory diagnosis of CNS and bloodstream infections in LMICs.

Brenda Anna Kwambana-Adams is a Wellcome International Intermediate Fellow and Senior Lecturer (Academic Career Track) at the Liverpool School of Tropical Medicine and the Malawi Liverpool Wellcome Programme (MLW). Brenda is also an Honorary Senior Research Fellow within the Division of Infection and Immunity at University College London (UCL).  Within MLW, Brenda co-leads the Vaccines Theme and heads the Pneumonia and Meningitis Pathogens Associate Research Group.

Her research focuses on characterizing the mechanisms influencing the transmission of respiratory pathogens using advanced 'omics' techniques, aiming to inform the development of more effective control strategies. Through her Wellcome Fellowship, Brenda is conducting an innovative vaccine-probe study to explore the role of under-fives in the transmission of Streptococcus pneumoniae within households.

In parallel, Brenda is developing tools for early, rapid, and accurate diagnosis of central nervous system (CNS) and bloodstream infections, which could significantly enhance case identification in resource-limited settings. She collaborates with the World Health Organization (WHO) and Regional Reference Laboratories to support surveillance of acute bacterial meningitis across Africa. Brenda's contributions extend to shaping global health policy. She contributed to developing the WHO guidelines for controlling pneumococcal outbreaks in the African 'meningitis belt' and the WHO Defeating Meningitis 2030 Global Roadmap. Brenda has won numerous awards including the prestigious MRC-LSHTM West Africa Global Health Research Fellowship.

University members only.

Forthcoming events

Will the next pandemic be caused by H5N1 influenza?

Monday, 02 June 2025, 1pm to 2pm @ Richard Doll Lecture Theatre

The world is currently experiencing a panzootic of H5N1 influenza. Wild birds have carried the virus across all continents and an unprecedented number of mammalian species have been infected including humans. What will it take for this virus to go pandemic, and does the introduction of the virus into dairy herds in USA bring that one step closer? Wendy will discuss the current knowledge on host range barriers that protect us from more frequent zoonoses and pandemic from bird flu, and show how we can use this scientific knowledge to risk assess the current situation.

Better treatment for tuberculosis

Monday, 09 June 2025, 1pm to 2pm @ BDI/OxPop Building LG seminar rooms

Resolving the genetic basis of type 2 diabetes in 125 000 Mexicans

Tuesday, 10 June 2025, 1pm to 2pm @ Richard Doll Lecture Theatre

The burden of drug resistant infections, the GRAM project

Monday, 16 June 2025, 1pm to 2pm @ BDI/OxPop Building LG seminar rooms